CL - Colgate-Palmolive Company
NYSE
->
Consumer Defensive
->
Household & Personal Products
New York,
United States
Type: Equity
CL price evolution
CL
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1110 | $1079 | $966 | |
| Short term investments | ||||
| Net receivables | $1712 | $1825 | $1813 | $1586 |
| Inventory | $2041 | $1922 | $1914 | $1934 |
| Total current assets | $5806 | $5646 | $5640 | $5279 |
| Long term investments | ||||
| Property, plant & equipment | $4421 | $4392 | $4497 | $4582 |
| Goodwill & intangible assets | $5134 | $5178 | $5297 | |
| Total noncurrent assets | $10834 | $10931 | $11114 | |
| Total investments | ||||
| Total assets | $16774 | $16480 | $16571 | $16393 |
| Current liabilities | ||||
| Accounts payable | $1625 | $1557 | $1646 | $1698 |
| Deferred revenue | ||||
| Short long term debt | $530 | $538 | $330 | |
| Total current liabilities | $5565 | $5350 | $5314 | $4741 |
| Long term debt | $7909 | $8146 | $8151 | $8219 |
| Total noncurrent liabilities | $10648 | $10640 | $10695 | |
| Total debt | $8676 | $8689 | $8549 | |
| Total liabilities | $16339 | $15998 | $15954 | $15436 |
| Shareholders' equity | ||||
| Retained earnings | $25814 | $25486 | $25164 | $25289 |
| Other shareholder equity | -$4074 | -$4128 | -$4019 | -$3937 |
| Total shareholder equity | $123 | $230 | $609 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $966 | $775 | $832 | $888 |
| Short term investments | $37 | |||
| Net receivables | $1586 | $1504 | $1297 | $1264 |
| Inventory | $1934 | $2074 | $1692 | $1673 |
| Total current assets | $5279 | $5113 | $4397 | $4338 |
| Long term investments | $75 | |||
| Property, plant & equipment | $4582 | $4307 | $3730 | $3716 |
| Goodwill & intangible assets | $5297 | $5272 | $5746 | $6718 |
| Total noncurrent assets | $11114 | $10618 | $10643 | $11582 |
| Total investments | ||||
| Total assets | $16393 | $15731 | $15040 | $15920 |
| Current liabilities | ||||
| Accounts payable | $1698 | $1551 | $1479 | $1393 |
| Deferred revenue | ||||
| Short long term debt | $330 | $25 | $51 | $267 |
| Total current liabilities | $4741 | $3979 | $4051 | $4404 |
| Long term debt | $8219 | $8766 | $7194 | $7334 |
| Total noncurrent liabilities | $10695 | $10921 | $10018 | $10415 |
| Total debt | $8549 | $8766 | $7245 | $7601 |
| Total liabilities | $15436 | $15330 | $14069 | $14819 |
| Shareholders' equity | ||||
| Retained earnings | $25289 | $24573 | $24350 | $23699 |
| Other shareholder equity | -$3937 | $401 | -$4386 | -$4345 |
| Total shareholder equity | $609 | $401 | $609 | $743 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5033 | $5058 | $5065 | |
| Cost of revenue | $1992 | $2026 | ||
| Gross Profit | $3074 | $3066 | $3039 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1939 | $1916 | ||
| Total operating expenses | $2005 | $1974 | $1992 | |
| Operating income | $1092 | $1047 | ||
| Income from continuing operations | ||||
| EBIT | $1034 | $979 | ||
| Income tax expense | $210 | $243 | $238 | |
| Interest expense | -$56 | $60 | $58 | |
| Net income | ||||
| Net income | $737 | $731 | $683 | |
| Income (for common shares) | $731 | $683 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $19457 | $17967 | $16471 | |
| Cost of revenue | $8131 | $7719 | $6454 | |
| Gross Profit | $11326 | $10248 | $10017 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $7151 | $6565 | $6019 | |
| Total operating expenses | $7342 | $7355 | $6132 | |
| Operating income | $3984 | $2893 | $3885 | |
| Income from continuing operations | ||||
| EBIT | $3469 | $2631 | $3646 | |
| Income tax expense | $937 | $693 | $787 | |
| Interest expense | $232 | $153 | $164 | |
| Net income | ||||
| Net income | $2300 | $1785 | $2695 | |
| Income (for common shares) | $2300 | $1785 | $2695 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $731 | $683 | $718 | |
| Operating activities | ||||
| Depreciation | $157 | $150 | $150 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $24 | $19 | $25 | |
| Total cash flows from operations | $990 | $681 | $1136 | |
| Investing activities | ||||
| Capital expenditures | -$117 | -$126 | -$197 | |
| Investments | -$4 | -$61 | $56 | |
| Total cash flows from investing | -$454 | -$111 | -$193 | -$143 |
| Financing activities | ||||
| Dividends paid | -$1275 | -$473 | -$394 | -$506 |
| Sale and purchase of stock | -$361 | -$173 | -$190 | |
| Net borrowings | $9 | $229 | -$344 | |
| Total cash flows from financing | -$2110 | -$845 | -$361 | -$992 |
| Effect of exchange rate | -$6 | -$3 | -$14 | $14 |
| Change in cash and equivalents | $268 | $31 | $113 | $15 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $2300 | $1785 | $2166 | $2695 |
| Operating activities | ||||
| Depreciation | $567 | $545 | $556 | $539 |
| Business acquisitions & disposals | -$809 | -$353 | ||
| Stock-based compensation | $122 | $125 | $135 | $107 |
| Total cash flows from operations | $3745 | $2556 | $3325 | $3719 |
| Investing activities | ||||
| Capital expenditures | -$705 | -$649 | -$567 | -$410 |
| Investments | -$4 | -$148 | -$19 | |
| Total cash flows from investing | -$742 | -$1601 | -$592 | -$779 |
| Financing activities | ||||
| Dividends paid | -$1749 | -$1691 | -$1679 | -$1654 |
| Sale and purchase of stock | -$748 | -$890 | -$896 | -$602 |
| Net borrowings | -$314 | $1647 | -$175 | -$564 |
| Total cash flows from financing | -$2793 | -$952 | -$2774 | -$2919 |
| Effect of exchange rate | -$19 | -$60 | -$15 | -$16 |
| Change in cash and equivalents | $191 | -$57 | -$56 | $5 |
News
Fundamentals
| Market cap | $77.89B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 817.01M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 2.40% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 25.35 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.04 |
| Quick ratio | 0.68 |